| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/24/1994 | DE4231675A1 Glycopeptide adjuvant for increasing antibody prodn. - formulated as optimised dose for dissolving in aq. antigen soln., more active than Freund's adjuvant and requires no oil emulsion |
| 03/23/1994 | EP0588750A2 Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0588578A1 Immunogens |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0587873A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587775A1 Induction of ctl responses to foreign antigens expressed in mycobacteria |
| 03/23/1994 | EP0587765A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587636A1 Fish vaccine for aeromonas salmonicida infection |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | EP0464124B1 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 03/23/1994 | CN1084218A Multiple particulate antigen delivery system |
| 03/23/1994 | CN1084066A Method for prepn. of yokl antibody |
| 03/22/1994 | US5296594 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 03/22/1994 | US5296382 Recombinant DNA clone containing a genomic fragment of PfHRP-II gene from Plasmodium falciparum |
| 03/22/1994 | US5296353 Evaluation and treatment of patients with progessive immunosuppression |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | WO1994005800A1 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/17/1994 | WO1994005784A1 Portable intron as an insertion vector for gene insertion |
| 03/17/1994 | WO1994005783A1 Novel haemophilus organism and vaccines containing the same |
| 03/17/1994 | WO1994005703A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
| 03/17/1994 | WO1994005700A2 Methods and reagents to detect and characterize norwalk and related viruses |
| 03/17/1994 | WO1994005698A1 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005691A1 Cd27 ligand |
| 03/17/1994 | WO1994005690A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | WO1994005329A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
| 03/17/1994 | WO1994005327A1 New hiv-1 isolates of a subtype and its differential diagnosis, vaccine against hiv-1 infection of this subtype and process for preparing and using the hiv-1 isolate |
| 03/17/1994 | WO1994005326A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| 03/17/1994 | WO1994005325A1 Vaccines against group c neisseria meningitidis |
| 03/17/1994 | WO1994005323A1 Method for induction of antigen-specific immune tolerance |
| 03/17/1994 | WO1994005311A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | WO1993018055A3 Peptides stimulating cytotoxic lymphocytes respone to hiv-1 gp160 |
| 03/17/1994 | CA2143417A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | CA2143299A1 Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2143186A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | CA2139743A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
| 03/17/1994 | CA2122630A1 Monoclonal antibody to cell surface protein of the bacterium neisseria meningitidis |
| 03/17/1994 | CA2122628A1 Method for induction of antigen-specific immune tolerance |
| 03/16/1994 | EP0586790A1 Amyloid precursor-like protein and uses thereof |
| 03/16/1994 | EP0586687A1 Trans-sialidase and methods of use and making thereof |
| 03/16/1994 | EP0586549A1 Selecting ligand agonists and antagonists |
| 03/16/1994 | EP0586532A1 Method of using substance p to treat allergy |
| 03/16/1994 | EP0586505A1 Heteroconjugate antibodies for treatment of hiv infection |
| 03/16/1994 | EP0586438A1 Hepatitis a virus production |
| 03/16/1994 | EP0429624B1 RADIOIMMUNOTHERAPY USING $g(a)-PARTICLES EMISSION |
| 03/16/1994 | CN1083704A Method of treatment of HIV-seropositive individuals with dietary whey proteins |
| 03/15/1994 | US5294548 Baculovirus coding for the polyprotein in a infected host cell |
| 03/15/1994 | US5294538 Enzyme inhibitor |
| 03/15/1994 | US5294441 Immunization; obtained from a pathogenic S. typhi having the cya and crp genes deactivated by genetic mutation |
| 03/15/1994 | CA2105646A1 Use of therapeutic agent from mycobacterium vaccae against hiv infections with aids |
| 03/15/1994 | CA2105629A1 Potentiation of immunogenic response |
| 03/15/1994 | CA1327749C Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli |
| 03/09/1994 | EP0586266A1 DNA fragments coding for the Neisseria meningitidis receptor fragments |
| 03/09/1994 | EP0586085A2 Veterinary method for the treatment of ketosis in livestock |
| 03/09/1994 | EP0586076A2 Recombinant adenovirus vaccines |
| 03/09/1994 | EP0586065A2 Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping using the same |
| 03/09/1994 | EP0586026A2 Characterization of a novel anti-p110 RB monoclonal antibody |
| 03/09/1994 | EP0586002A2 Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them |
| 03/09/1994 | EP0585986A1 Method and means for site directed therapy |
| 03/09/1994 | EP0585983A2 Nucleotide vector comprising a translation inhibition factor gene, and IRES region and a desired gene |
| 03/09/1994 | EP0585963A1 Monoclonal antibodies to CMP-170 antigen on activated endothelial cells |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585801A2 Bone-related cadherin-like protein and process for its production |
| 03/09/1994 | EP0585705A1 Use of anti-TNF to treat bacterial meningitis |
| 03/09/1994 | EP0585681A2 Use of IL-4 receptors for the therapy, prophylaxis and diagnosis of allergic, viral, paracitic and bacterial diseases, as well as of fungal infections |
| 03/09/1994 | EP0585570A1 Antigranulocyte antibody construct, preparation and use thereof |
| 03/09/1994 | EP0585549A2 Method for producing ectoprotein of hepatitis C virus |
| 03/09/1994 | EP0585398A1 Hcv genomic sequences for diagnostics and therapeutics |
| 03/09/1994 | EP0585390A1 Stealth virus detection in the chronic fatigue syndrome |
| 03/09/1994 | EP0585384A1 Purification and cloning of p62 |
| 03/09/1994 | EP0585381A1 THE ASTROVIRUS HUMAN GASTROENTERITIS AGENTS AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
| 03/09/1994 | EP0585364A1 Ctaa 81av78, the antigen recognized by human monoclonal antibody 81av78 |
| 03/09/1994 | EP0585287A1 Methods for producing members of specific binding pairs |
| 03/09/1994 | EP0585267A1 Herpesvirus particles and vaccine |
| 03/09/1994 | EP0585257A1 Dna and amino acid sequence specific for natural killer cells |
| 03/09/1994 | EP0585242A1 Wound healing |
| 03/09/1994 | EP0585216A1 Im peptides |
| 03/09/1994 | CN1083524A Deletion mutants as vaccines for cholera |
| 03/08/1994 | US5292869 Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
| 03/08/1994 | US5292867 Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin |
| 03/08/1994 | US5292840 Acrylic amide adducts |
| 03/08/1994 | US5292662 Position-specific insertion vectors and method of using same |
| 03/08/1994 | US5292513 Method for nonspecific cellular immune stimulation |
| 03/08/1994 | US5292510 WS7622A mono- or di- sulfate, process for preparation thereof and use thereof |
| 03/08/1994 | US5292506 Muramyldipeptide derivatives and influenza vaccine comprising the derivatives |
| 03/08/1994 | CA1327676C Isolation of an immunoglobulin rich fraction from whey |
| 03/08/1994 | CA1327523C Antigen immunogenicity |
| 03/03/1994 | WO1994004922A1 Methods for monitoring effectiveness of interferon therapy in individuals with hcv infections |